These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14756456)

  • 1. Is oral immunotherapy too good to be true?
    Ledford DK
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):1-2. PubMed ID: 14756456
    [No Abstract]   [Full Text] [Related]  

  • 2. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
    Durham SR
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe.
    Cox L; Calderon MA
    Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-dependence of sublingual immunotherapy shown by meta-analysis.
    Frati F; Incorvaia C; Scurati S; Sensi L; Marcucci F
    J Allergy Clin Immunol; 2011 Apr; 127(4):1076-7; author reply 1077-8. PubMed ID: 21306764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
    Klein F
    MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
    [No Abstract]   [Full Text] [Related]  

  • 7. [Grazax--treatment for grass pollen hay fever].
    Svendsen UG
    Ugeskr Laeger; 2008 Jan; 170(3):135-7. PubMed ID: 18208728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 9. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity of product-specific assessments or restrictions of meta-analyses to well-designed and well-powered studies.
    Sieber J;
    J Allergy Clin Immunol; 2011 Apr; 127(4):1075-6; author reply 1077-8. PubMed ID: 21306765
    [No Abstract]   [Full Text] [Related]  

  • 13. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
    [No Abstract]   [Full Text] [Related]  

  • 18. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
    Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
    J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence based overview of sublingual immunotherapy in children.
    Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.